サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：微生物発酵技術の世界市場：2023-2030年
市場調査レポート
商品コード
1351017

微生物発酵技術の世界市場：2023-2030年

Global Microbial Fermentation Technology Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 132 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
微生物発酵技術の世界市場：2023-2030年
出版日: 2023年09月05日
発行: Orion Market Research
ページ情報: 英文 132 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の微生物発酵技術市場は、予測期間中（2023-2030年）にCAGR 5.9％で成長すると予測されています。世界の微生物発酵技術市場の成長を促進する主な要因には、化学物質、材料、バイオ燃料、食事、医薬品を生成するために使用される工業発酵の増加が含まれます。発酵技術を採用する主な目的は、培養ベースまたは分子アプローチを使用して代謝経路を変更することです。発酵は、組み換えタンパク質、ワクチン、ホルモンなどの組み換え製品を製造するために製薬会社が使用する一般的な方法です。例えば、2023年5月、Ardra Inc.は、植物性食肉代替品、健康・栄養添加物、天然保存料などの天然食品素材を製造しています。Ardra社は、精密発酵技術により、より持続可能で、より手頃な価格で、信頼性の高い天然素材を生産しています。

セグメント別の展望

抗生物質サブセグメントが世界の微生物発酵技術市場でかなりのシェアを占めると予測される

用途別では、抗生物質サブセグメントが世界の微生物発酵技術市場でかなりのシェアを占めると予想されます。このセグメントの成長は、世界の健康への関心の高まり、製薬業界の投資、新菌株の発見、バイオテクノロジーの進歩、抗生物質へのニーズの高まりに起因しています。生産能力を高めるために、新しい設備と改善されたプロセスは、企業にとって重要な持続可能性の改善をもたらします。例えば、2023年2月、エボニック・インダストリーズAGのアニマル・ニュートリション・カンパニー・ラインは、抗菌性成長促進剤により重点を置き、動物の健康とパフォーマンスを保証し、人間の健康を守り、世界的に高まる高品質の動物性タンパク質への需要を満たすソリューションの提供に努めています。

地域別展望

世界の微生物発酵技術市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに区分されます。このうち北米は、世界全体の市場で突出したシェアを占めると予想されています。生物製剤の製造が進化していることが、この地域の市場を牽引する主な要因です。同地域の主要な市場プレイヤーには、Ferment.Co、Perfect Day、Geltor, Inc.、The EVERY Co.などが含まれます。

アジア太平洋地域は世界の微生物発酵技術市場において著しいCAGRで成長する見込み

すべての地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予想されています。生物製剤の研究開発と製品開発への企業の関与が増加していることと、この地域に多数の開発受託機関が存在することが、この地域の成長に寄与しています。この地域の微生物発酵技術に対するニーズは、バイオ医薬品のアウトソーシングに影響を与える諸要因の収束の結果として高まると思われます。国内需要に対応するため、中国では多くのバイオプロセス工場が建設される予定です。

強力な規制の枠組みもアジア太平洋市場を形成する重要な要因です。インド、中国、日本は、バイオ医薬品を取り巻くプロモーション、開発、承認、法的慣行に関するガイドラインを改善する試みを続けています。中国はアジア太平洋地域における主要な収益貢献国です。中国産業に影響を与える主な要因の一つは、生物製剤製造の変化です。バイオ医薬品の研究開発のための支出が増加し、GMP製造のための信じられないほど革新的な技術が採用された結果、市場が成長しました。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Danone S.A.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • F. Hoffmann-La Roche AG.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Koninklijke DSM NV.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 微生物発酵技術の世界市場：技術タイプ別
    • フェドバッチ発酵
    • 固体発酵
    • 連続攪拌タンクリアクター
  • 微生物発酵技術の世界市場：用途別
    • 抗生物質
    • ワクチン
    • 溶剤
    • 中間化合物
  • 微生物発酵技術の世界市場：エンドユーザー別
    • バイオ医薬品産業
    • 食品・飼料産業
    • CROおよびCMO
    • 学術研究機関

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Abolis Biotechnologies
  • Biocon Ltd.
  • BioVectra Inc.
  • BIOZEEN
  • CHAIN Biotechnology Ltd.
  • Corbion N.V.
  • EKF Diagnostics
  • EV Biotech B.V.
  • Lonza Group AG
  • Microbial Discovery Group
  • Novozymes A/S.
  • PILI
  • TerraVia Holdings, Inc.
  • Unibio
  • Wisconsin BioProducts
図表

LIST OF TABLES

  • 1. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL FED-BATCH MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL SOLID-STATE MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CONTINUOUS STIRRED-TANK MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION TYPE, 2022-2030 ($ MILLION)
  • 6. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR ANTIBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SOLVENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR INTERMEDIARY COMPOUNDS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR BIO-PHARMACEUTICAL INDUSTRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR FOOD AND FEED INDUSTRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR CROS AND CMOS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR ACADEMIC RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 20. EUROPEAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. EUROPEAN MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL FED-BATCH MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL SOLID-STATE MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL CONTINUOUS STIRRED-TANK MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION TYPE, 2022 VS 2030 (%)
  • 6. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR ANTIBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR SOLVENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR INTERMEDIARY COMPOUNDS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 11. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR BIO-PHARMACEUTICAL INDUSTRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR FOOD AND FEED INDUSTRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR CROS AND CMOS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY FOR ACADEMIC RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 16. US MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF EUROPE MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SOUTH KOREA MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MICROBIAL FERMENTATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027617

Title: Global Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Technology (Fed-Batch Fermentation, Solid-State Fermentation, and Continuous Stirred-Tank Reactor), by Application (Antibiotics, Vaccines, Solvents, and Intermediary compounds), and by End-Users (Bio-Pharmaceutical Industries, Food and Feed Industries, CROs and CMOs, and Academic Research Institutes),Forecast Period (2023-2030).

The global microbial fermentation technology market is anticipated to grow at a CAGR of 5.9% during the forecast period (2023-2030). The major factor driving the global microbial fermentation technology market growth includes the rising industrial fermentation, which is used to generate chemicals, materials, biofuels, meals, and medicines. The main purpose in adoption of fermentation technology is to alter the metabolic pathways using cultivation-based or molecular approaches. Fermentation is a common method used by pharmaceutical companies to manufacture recombinant goods such as recombinant proteins, vaccines, and hormones. For instance, in May 2023, Ardra Inc. produces natural food ingredients such as plant-based meat substitutes, health and nutritional additives, and natural preservatives. Ardra produces natural ingredients more sustainably, more affordably, and with reliable supply via precision fermentation technology.

Segmental Outlook

The global microbial fermentation technology market is segmented by technology, application, and end-users. Based on the technology, the market is sub-segmented into fed-batch fermentation, solid-state fermentation, and continuous stirred-tank reactors. Based on the application, the market is sub-segmented into antibiotics, vaccines, solvents, and intermediary compounds. Further, on the basis of end-users, the market is sub-segmented into bio-pharmaceutical industries, food and feed industries, CROs and CMOs, and academic research institutes. Among the end-users, the bio-pharmaceutical industries sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of emerging innovative technologies such as ultrasound, ohmic heating, MEF, PEF, and cold plasma, these have significantly improved the market for fermentation technologies.

The Antibiotic Sub-Segment is Anticipated to Hold a Considerable Share of the Global Microbial Fermentation Technology Market

Among the application, the antibiotic sub-segment is expected to hold a considerable share of the global microbial fermentation technology market. The segmental growth is attributed to the growing influence of global health concerns, pharmaceutical industry investment, the discovery of new strains, advancements in biotechnology, and the increasing need for antibiotics. To boost production capacity, the new facilities and improved processes bring important sustainability improvements for the company. For instance, in February 2023, Evonik Industries AG's Animal Nutrition Company Line, with a larger focus on antimicrobial growth promoters, strives to offer solutions that assure the health and performance of the animal, protect human health, and meet the growing demand for high-quality animal protein globally.

Regional Outlook

The global microbial fermentation technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe. The evolving landscape of the manufacturing of biologics is a major driving factor for the market in the region. The key market players in the region include Ferment.Co, Perfect Day, Geltor, Inc., The EVERY Co. and others.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Microbial Fermentation Technology Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Growing company involvement in biologics research and product development, together with the presence of a sizable number of contract development organizations in the area, are both factors contributing to regional growth. The region's need for microbial fermentation technology would rise as a result of the convergence of the factors affecting biopharmaceutical outsourcing. To address domestic demand, a number of bioprocessing plants are going to be built in China.

The strong regulatory framework is another key factor in shaping the Asia-Pacific market. India, China, Japan continues to make attempts to improve guidelines regarding the promotion, development, approval, and legal practice surrounding biopharmaceutical products. China is the key revenue contributor in the Asia-Pacific region. One of the key factors influencing the Chinese industry is the way biologics manufacturing is changing. The market has grown as a result of growing spending for biopharmaceutical research and development as well as the adoption of incredibly innovative technology for GMP manufacturing.

Market Players Outlook

The major companies serving the global microbial fermentation technology market includes Abolis Biotechnologies, BioVectra Inc., Microbial Discovery Group, Novozymes A/S, TerraVia Holdings, Inc., and others. The market players are considerably contributing to market growth through the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, Novus International Inc., a multinational animal feed and health firm, acquired Agrivida Inc. As a result of the acquisition, Novus has control of the patented INTERIUS technology that Agrivida created to embed feed ingredients inside grain.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global microbial fermentation technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Danone S.A.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. F. Hoffmann-La Roche AG.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Koninklijke DSM NV.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Microbial Fermentation Technology Market by Technology Type
    • 4.1.1. Fed-Batch Fermentation
    • 4.1.2. Solid-State Fermentation
    • 4.1.3. Continuous Stirred-Tank Reactor
  • 4.2. Global Microbial Fermentation Technology Market by Application
    • 4.2.1. Antibiotics
    • 4.2.2. Vaccines
    • 4.2.3. Solvents
    • 4.2.4. Intermediary compounds
  • 4.3. Global Microbial Fermentation Technology Market by End-User
    • 4.3.1. Bio-Pharmaceutical Industries
    • 4.3.2. Food and Feed Industries
    • 4.3.3. CROs and CMOs
    • 4.3.4. Academic Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abolis Biotechnologies
  • 6.2. Biocon Ltd.
  • 6.3. BioVectra Inc.
  • 6.4. BIOZEEN
  • 6.5. CHAIN Biotechnology Ltd.
  • 6.6. Corbion N.V.
  • 6.7. EKF Diagnostics
  • 6.8. EV Biotech B.V.
  • 6.9. Lonza Group AG
  • 6.10. Microbial Discovery Group
  • 6.11. Novozymes A/S.
  • 6.12. PILI
  • 6.13. TerraVia Holdings, Inc.
  • 6.14. Unibio
  • 6.15. Wisconsin BioProducts